This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Agharazii, M. Articles by Lebel, M. Search for Related Content PubMed PubMed Citation Articles by Agharazii, M. Articles by Lebel, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CAPTOPRIL SODIUM Related Collections Clinical Studies Other etiology Other diagnostic testing

(Hypertension. 2001;37:1440.)
© 2001 American Heart Association, Inc.

Scientific Contributions

Captopril Suppression Versus Salt Loading in Confirming Primary Aldosteronism

Mohsen Agharazii; Pierre Douville; John H. Grose; Marcel Lebel

From CHUQ, L’Hôtel-Dieu de Québec Hospital, and Department of Medicine, Faculty of Medicine, Laval University, Québec, Canada.

Correspondence to Marcel Lebel, MD, FRCPC, CHUQ, L’Hôtel-Dieu de Québec Hospital, 11 côte du Palais, Québec, QC, Canada, G1R 2J6. E-mail marcel.lebel{at}crhdq.ulaval.ca

Abstract—This prospective study was designed to compare the captopril suppression test with the salt-loading approach to confirm the diagnosis of primary aldosteronism. A total of 49 patients were referred with a presumed diagnosis of primary aldosteronism. The captopril test was performed in the morning with patients in the seated position after overnight fasting. Blood samples for plasma aldosterone were obtained before captopril administration (25 mg PO) and again 2 hours later. Patients were then subjected to a high salt diet (300 mmol sodium per day for 3 days). On the third day, urinary sodium (24 hours) was measured, and plasma aldosterone levels were measured at 8:00 AM (recumbent) and at noon (standing). Of the 49 patients, 44 had nonsuppressible aldosterone concentrations with all the clinical characteristics of primary aldosteronism: 22 patients had surgically confirmed unique adenoma, and 22 patients had presumed bilateral hyperplasia. There was a significant correlation between plasma aldosterone values of salt-loaded patients (mean of 8:00 AM and noon results) and the values 2 hours after captopril administration (r=0.8, P<0.01). Plasma aldosterone cumulative distribution curves in primary aldosteronism patients (adenoma and hyperplasia) were not significantly different between the 2 suppression tests. Our results showed that the captopril suppression test is as effective as sodium loading in confirming the diagnosis of primary aldosteronism.

Key Words: aldosterone • captopril • sodium, dietary • hypertension, essential • renin

This article has been cited by other articles:

				J. W. Funder, R. M. Carey, C. Fardella, C. E. Gomez-Sanchez, F. Mantero, M. Stowasser, W. F. Young Jr., and V. M. Montori Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3266 - 3281. [Abstract] [Full Text] [PDF]

				V.C. Wu, S.C. Chueh, H.W. Chang, W.C. Lin, K.L. Liu, H.Y. Li, Y.H. Lin, K.D. Wu, and B.S. Hsieh Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia QJM, January 1, 2008; 101(1): 13 - 22. [Abstract] [Full Text] [PDF]

				P. Mulatero, C. Bertello, C. Garrone, D. Rossato, G. Mengozzi, A. Verhovez, F. Fallo, and F. Veglio Captopril Test Can Give Misleading Results in Patients With Suspect Primary Aldosteronism Hypertension, August 1, 2007; 50(2): e26 - e27. [Full Text] [PDF]

				G. P. Rossi, A. Belfiore, G. Bernini, G. Desideri, B. Fabris, C. Ferri, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, et al. Comparison of the Captopril and the Saline Infusion Test for Excluding Aldosterone-Producing Adenoma Hypertension, August 1, 2007; 50(2): 424 - 431. [Abstract] [Full Text] [PDF]

				P. Mulatero, F. Rabbia, A. Milan, C. Paglieri, F. Morello, L. Chiandussi, and F. Veglio Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism Hypertension, December 1, 2002; 40(6): 897 - 902. [Abstract] [Full Text] [PDF]

				O. L. Castro, X. Yu, and D. C. Kem Diagnostic Value of the Post-Captopril Test in Primary Aldosteronism Hypertension, April 1, 2002; 39(4): 935 - 938. [Abstract] [Full Text] [PDF]